Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/14/2010US20100260763 Polypeptides, antibody variable domains and antagonists methods for
10/14/2010US20100260752 Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria
10/14/2010US20100260743 Solubilization and Targeted Delivery of Drugs With Self-Assembling Amphiphilic Polymers
10/14/2010US20100260720 Prevention of opportunistic infections in immune-compromised subjects
10/14/2010US20100260717 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260713 Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
10/14/2010US20100260712 Use of human antibody capable of neutralizing hepatitis b virus for the prevention or treatment of hepatitis b virus infection
10/14/2010US20100260711 3-aminosulfonyl substituted indole derivatives and methods of use thereof
10/14/2010US20100260710 Macrocyclic serine protease inhibitors
10/14/2010US20100260709 Organic compounds and their uses
10/14/2010US20100260708 Hepatitis C Virus Inhibitors
10/14/2010US20100260706 Compositions and methods for improving production of recombinant polypeptides
10/14/2010US20100260704 Human interferon-gamma (infgamma) variants
10/14/2010US20100260687 Personal care compositions including polyurethane dispersions
10/14/2010DE102009015917A1 Use of an active agent comprising resveratrol, thymol, xanthohumol or vitamin C for inhibition and/or prophylaxis of e.g. eryptosis, acute renal failure, anemia, shock, atherosclerosis, thrombosis, diabetes mellitus and sickle cell anemia
10/14/2010CA2758365A1 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
10/14/2010CA2758149A1 Inhibitors of hiv replication
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/14/2010CA2758047A1 Hepatitis c virus inhibitors
10/14/2010CA2757963A1 Hepatitis c virus inhibitors
10/14/2010CA2757828A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757574A1 Inhibitors of bacterial type iii secretion system
10/14/2010CA2757269A1 Hepatitis c virus inhibitors
10/14/2010CA2756727A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
10/14/2010CA2756104A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010CA2753151A1 Substituted piperidines as ccr3 antagonists
10/13/2010EP2238980A1 Aqueous compositions containing metronidazole
10/13/2010EP2238253A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
10/13/2010EP2238142A2 Macrocyclic indoles as hepatitis c virus inhibitors
10/13/2010EP2238138A1 Tricyclic nitrogen compounds and their use as antibacterial agents
10/13/2010EP2238135A1 Naphthyridin-2(1h) -one compounds useful as antibacterials
10/13/2010EP2237794A2 Chimeric hiv fusion proteins as vaccines
10/13/2010EP2237769A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals
10/13/2010EP2237684A2 Agonists for antimicrobial peptide systems
10/13/2010EP1931358B1 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
10/13/2010EP1783129B1 Spiropiperidyl rifamycins for the treatment of microbacterial infections
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1480644B1 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010CN201602811U 多功能缝线 Multifunction sutures
10/13/2010CN201602500U 一种保健枕 One kind Pillow
10/13/2010CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor
10/13/2010CN1931258B Preparation process and use of loquat seed extract
10/13/2010CN1927251B Medicament for animals with heat clearing and detoxicating functions and preparing method thereof
10/13/2010CN1823890B Formula of oral Chinese medicine used for treating virus myocarditis
10/13/2010CN1799586B Cold treating capsule and its preparation method
10/13/2010CN1737147B Heat shock protein 65- multiple epitope hepatitis B virus core antigen recombinant protein (HSP65-HBcAg)
10/13/2010CN1646473B Novel curcumin analogues and uses thereof
10/13/2010CN1563088B Specific composite IgY for anti influenza and preparation
10/13/2010CN101861330A Polypeptide compound
10/13/2010CN101861300A Crystalline forms of tigecycline hydrochloride
10/13/2010CN101857861A Molecular marker for immunological recognition and construction and application thereof
10/13/2010CN101857841A Marine fungi aspergillus unguis strain, active extract thereof and preparation method and use of active extract thereof and active components thereof
10/13/2010CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/13/2010CN101857613A Rupestonic acid glycolipid derivative and preparation method and applications thereof
10/13/2010CN101857564A Method for removing dioxane from Ftibamzone raw material
10/13/2010CN101857562A Synthetic method of QseC ligand derivatives with role of inhibiting bacterial virulence
10/13/2010CN101857540A Method for producing adipic acid, hexamethylenediamine hydrochloride and polyhexamethylene (di)guanidine chloride from nylon-66 through depolymerization
10/13/2010CN101856498A Anti-septic shock medicine compound and application thereof
10/13/2010CN101856495A Medical composition and mixture for treating chicken infectious bursal disease and preparation method thereof
10/13/2010CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof
10/13/2010CN101856470A Chinese medicament for treating hepatitis B
10/13/2010CN101856453A Nanomedicine composition for resisting primary bronchitis virus and preparation method thereof
10/13/2010CN101856447A Capsule capable of clearing heat and purging fire
10/13/2010CN101856421A Medicament for treating herpes zoster and preparation method thereof
10/13/2010CN101856416A Chinese herbal medicament oral liquid for treating chicken colibacillosis
10/13/2010CN101856402A Medicament composition for adjuvant treating hepatitis
10/13/2010CN101856397A Medicinal composition for treating hepatitis B and preparation method thereof
10/13/2010CN101856396A Dispersible tablet for treating hepatitis B and preparation method thereof
10/13/2010CN101856376A Chinese medicament for treating dermatophytosis
10/13/2010CN101856358A Medicinal composition for treating vaginitis
10/13/2010CN101856356A Cefazedone sodium composition powder injection
10/13/2010CN101856355A Therapeutical effect of atabrine and substitutes thereof on hepatitis B
10/13/2010CN101856347A Extract of leontopodic acid plant and application of active ingredients thereof in treating hepatitis
10/13/2010CN101856335A Azithromycin composite freeze-dried powder for injection
10/13/2010CN101856333A Freeze-dried powder injection of cefamandole nafate and preparation method thereof
10/13/2010CN101856332A Method for preparing 8, 9-single-epoxy brevifolin PLGA microspheres
10/13/2010CN101856328A Ketoconazole foaming agent and preparation method thereof
10/13/2010CN101856326A Method for preparing medical lycorine emulsion
10/13/2010CN101856323A Beta-CD inclusion suppository containing rana chensinensis antibacterial peptide and preparation method thereof
10/13/2010CN101530393B Clindamycin phosphate lipidosome freeze-dried preparation
10/13/2010CN101502631B Synergistic medicament composition containing Aolamite and Chinese medicine extract
10/13/2010CN101502589B Chinese and western medicinal composition containing bifendate for auxiliary treatment of hepatitis
10/13/2010CN101502572B Auxiliary Chinese and western medicinal composition for treating hepatitis
10/13/2010CN101502551B Synergistic composition containing bifendate
10/13/2010CN101411717B Composition for treating acute enteritis and diarrhea
10/13/2010CN101396371B Content determination method of Tibet crude-medicine processing material and new use thereof
10/13/2010CN101361895B Traditional Chinese medicine combination for treating measles complicated pneumonia
10/13/2010CN101333219B Penem derivates with mercapto pyrrolidine formamide benzene alkyl heterocycle
10/13/2010CN101328178B Penem derivates containing thiophen substituted sulfhydryl pyrrolidine
10/13/2010CN101323615B Pennem derivates containing formamide heterocycle sulfonic acid amide sulfhydryl pyrrolidine
10/13/2010CN101317847B Medicament composition for eyes or nose, and uses thereof
10/13/2010CN101280292B Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
10/13/2010CN101279978B Separation and purification method of cefathiamidine and preparation of cefathiamidine power injection
10/13/2010CN101275132B SiRNA capable of inhibiting influenza A virus replication and coding sequence thereof
10/13/2010CN101245081B Novel cephalosporin derivative
10/13/2010CN101244151B Medicament for treating dysentery